Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552705 · ClinicalTrials.gov registry record · Phase 2
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
A Phase 2 study of Anterior Cruciate Ligament Reconstruction, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03552705 is a Phase 2 study of Anterior Cruciate Ligament Reconstruction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 290-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03552705, a Phase 2 study of Anterior Cruciate Ligament Reconstruction, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients who tear their ACL are at high risk for developing arthritis (post-traumatic osteoarthritis-PTOA) just 10 years later. Joint bleeding and inflammation contribute to deterioration of joint health. This study will determine whether treatment with Tranexamic Acid (TXA), an FDA approved medication that reduces bleeding right after ACL injury and reconstructive surgery reduces inflammation and improves joint health as a new strategy to prevent or delay the onset of PTOA.
Conditions Studied
Interventions
- DRUG Tranexamic Acid
- DRUG Placebos
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2027-01-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03552705
The ClinicalTrials.gov registry entry for NCT03552705 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 290-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (83% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT03552705 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03552705 about?
NCT03552705 is a clinical study titled "The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients". Patients who tear their ACL are at high risk for developing arthritis (post-traumatic osteoarthritis-PTOA) just 10 years later. Joint bleeding and inflammation contribute to deterioration of joint health. This study will determine whether treatment with Tranexamic Acid (TXA), an FDA approved medicat...
What is the current status of trial NCT03552705?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2019-08-01. Estimated completion is 2027-01-14.
What conditions does trial NCT03552705 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.
What interventions are being tested in trial NCT03552705?
The interventions under investigation include: Tranexamic Acid (DRUG), Placebos (DRUG).
Who is sponsoring clinical trial NCT03552705?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03552705 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
RECRUITING · Phase 2
-
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
RECRUITING · NA
-
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
RECRUITING · Phase 4
-
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
RECRUITING · Phase 1
-
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
RECRUITING · NA
-
Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.